Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $335K | +1.02K | +23.89% | $328.65 | 5.29K | Feb 4, 2025 | Direct | |
transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $286K | +1.1K | +20.85% | $259.56 | 6.39K | Feb 4, 2025 | Direct | |
transaction | LII | Common Stock, Par Value $0.01 Per Share | Disposed to Issuer | -$405K | -695 | -10.87% | $582.41 | 5.7K | Feb 4, 2025 | Direct | |
transaction | LII | Common Stock, Par Value $0.01 Per Share | Disposed to Issuer | -$373K | -641 | -11.25% | $582.41 | 5.06K | Feb 4, 2025 | Direct | |
transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$417K | -715 | -14.14% | $582.59 | 4.34K | Feb 4, 2025 | Direct | F1 |
transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$166K | -285 | -6.57% | $584.06 | 4.06K | Feb 4, 2025 | Direct | |
transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$458K | -787 | -19.4% | $581.96 | 3.27K | Feb 4, 2025 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -1.02K | -100% | $0.00 | 0 | Feb 4, 2025 | Common Stock, Par Value $0.01 Per Share | 1.02K | $328.65 | Direct | F2 |
transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -1.1K | -49.98% | $0.00 | 1.1K | Feb 4, 2025 | Common Stock, Par Value $0.01 Per Share | 1.1K | $259.56 | Direct | F3 |
Id | Content |
---|---|
F1 | Reflects a weighted average sale price of $582.59 at prices ranging from $582.410 to $583.130 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
F2 | One third of the Stock Appreciation Rights became exercisable on 12/10/2022 and each year thereafter. The entire grant became fully exercisable on 12/10/2024. |
F3 | One third of the Stock Appreciation Rights became exercisable on 12/09/2023 and each year thereafter. The entire grant will become fully exercisable on 12/09/2025. |